Enanta Pharmaceuticals ENTA
NASDAQ ENTA
$11.55 -0.05 (-0.43%)
As of: Nov 12, 2026 · 9:30 AM EST

Enanta Pharmaceuticals (ENTA) Return on Capital Employed [ROCE] (2013 - 2026)

Updated

Enanta Pharmaceuticals' Return on Capital Employed [ROCE] came in at -23.34% for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 12.86 percentage points from -36.20% a year earlier but down 1.43 percentage points from the prior quarter.

Analysis

Enanta Pharmaceuticals (ENTA) Return on Capital Employed [ROCE] (2013 - 2026) Analysis & Trends

For FY2025 (ended Sep 30, 2025), Enanta Pharmaceuticals' Return on Capital Employed [ROCE] was -30.47%, up 3.16 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a five-year change of -21.49 percentage points (FY2020 to FY2025).
  • Going back by fiscal year, Return on Capital Employed [ROCE] was -33.62% in FY2024 (+4.91 pp), -38.54% in FY2023 (-5.71 pp), -32.83% in FY2022 (-7.12 pp) and -25.70% in FY2021 (-16.73 pp).
  • The five-year range for quarterly Return on Capital Employed [ROCE] is -42.34% (fiscal Q2 2023) to -21.91% (fiscal Q2 2026).
  • Year-over-year, Return on Capital Employed [ROCE] has increased for four consecutive quarters, with an average year-over-year change of +4.23 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in fiscal Q2 2026 (a gain of 13.32 percentage points), and the weakest in fiscal Q4 2021 (a drop of 18.06 percentage points).
  • Business Quant data shows ENTA's Return on Capital Employed [ROCE] at -21.91% (Q2 2026), -28.06% (Q1 2026) and -35.22% (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Enanta Pharmaceuticals 326.73 Mn -401.27 Mn - -23.34%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -23.34%
Mar 31, 2026 -21.91%
Dec 31, 2025 -28.06%
Sep 30, 2025 -35.22%
Jun 30, 2025 -36.20%
Mar 31, 2025 -35.23%
Dec 31, 2024 -35.19%
Sep 30, 2024 -36.85%
Jun 30, 2024 -35.31%
Mar 31, 2024 -36.95%
Dec 31, 2023 -37.10%
Sep 30, 2023 -32.99%
Jun 30, 2023 -38.88%
Mar 31, 2023 -42.34%
Dec 31, 2022 -36.47%
Sep 30, 2022 -35.34%
Jun 30, 2022 -34.99%
Mar 31, 2022 -33.55%
Dec 31, 2021 -31.78%
Sep 30, 2021 -26.83%
API Access

Enanta Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ENTA&period=max&api_key=YOUR_API_KEY